VOR33
VBP101
Phase 2 mab terminated
Quick answer
VOR33 for Leukemia, Myeloid, Acute is a Phase 2 program (mab) at Vor Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vor Biopharma
- Indication
- Leukemia, Myeloid, Acute
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated